Cumberland Pharmaceuticals (CPIX) Debt Ratio (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Debt Ratio of 0.07 for Q1 2026, up 8.21% sequentially from 0.07 in Q4 2025, and down 1.49% YoY from 0.07 in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Debt Ratio (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Debt Ratio for 16 years, with the latest figure at 0.07 in Q1 2026.
- Quarterly Debt Ratio fell 1.49% year-over-year to 0.07 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.07 (down 1.49% YoY) and the FY2025 annual result came in at 0.07, down 66.25% from the prior year.
- Debt Ratio advanced to 0.07 in Q1 2026 per CPIX's latest filing, from 0.07 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.21 in Q3 2024 and troughed at 0.07 in Q4 2025.
- A 5-year average of 0.15 and a median of 0.17 in 2022 frame the typical range for Debt Ratio.
- The sharpest annual moves came in 2024 and 2025: Debt Ratio surged 42.37% in 2024, then tumbled 66.25% in 2025.
- Over 5 years, Debt Ratio stood at 0.17 in 2022, then slipped by 10.33% to 0.16 in 2023, then increased by 29.28% to 0.2 in 2024, then sank by 66.25% to 0.07 in 2025, then climbed by 8.21% to 0.07 in 2026.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.07, 0.07, and 0.08 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -0.13 |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 0.42 |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.32 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 0.38 |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.29 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 0.12 |
| 10 | Cumberland Pharmaceuticals | 116.56 Mn | 112.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.07 |
| Dec 31, 2025 | 0.07 |
| Sep 30, 2025 | 0.08 |
| Jun 30, 2025 | 0.08 |
| Mar 31, 2025 | 0.07 |
| Dec 31, 2024 | 0.20 |
| Sep 30, 2024 | 0.21 |
| Jun 30, 2024 | 0.20 |
| Mar 31, 2024 | 0.20 |
| Dec 31, 2023 | 0.16 |
| Sep 30, 2023 | 0.15 |
| Jun 30, 2023 | 0.15 |
| Mar 31, 2023 | 0.18 |
| Dec 31, 2022 | 0.17 |
| Sep 30, 2022 | 0.19 |
| Jun 30, 2022 | 0.21 |
| Mar 31, 2022 | 0.21 |
| Dec 31, 2021 | 0.18 |
| Sep 30, 2021 | 0.17 |
| Jun 30, 2021 | 0.16 |